Is doxycycline (Doxycycline) effective against Methicillin-resistant Staphylococcus aureus (MRSA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Doxycycline can be effective against some strains of MRSA, but it is not considered a first-line treatment in most cases, and its use should be guided by susceptibility testing and clinical judgment, as recommended by the 2018 WSES/SIS-E consensus conference 1. The effectiveness of doxycycline against MRSA can vary depending on the specific strain and its susceptibility pattern. According to the Infectious Diseases Society of America (IDSA) guidelines, doxycycline is an option for empirical coverage of community-acquired MRSA (CA-MRSA) in outpatients with skin and soft tissue infections (SSTIs) 1. However, other antibiotics such as trimethoprim-sulfamethoxazole, clindamycin, or vancomycin are often preferred for treating MRSA infections. Some key points to consider when using doxycycline for MRSA infections include:

  • The typical dose for adults is 100 mg twice daily for 7-14 days, depending on the severity and location of the infection 1.
  • Doxycycline works by inhibiting protein synthesis in bacteria, but some MRSA strains may have developed resistance mechanisms against this action.
  • Proper wound care and infection control measures are also crucial in managing MRSA infections, regardless of the antibiotic chosen.
  • The choice of antibiotic should be based on susceptibility testing whenever possible, and doxycycline should be used in conjunction with other treatments, such as incision and drainage, as needed. It's essential to note that the most recent and highest-quality study, the 2018 WSES/SIS-E consensus conference, recommends doxycycline as an option for oral antibiotic coverage of MRSA in patients with SSTIs, but also emphasizes the importance of individualized treatment and susceptibility testing 1.

From the Research

Effectiveness of Doxycycline against MRSA

  • Doxycycline is often used to treat community-acquired MRSA (CA-MRSA) skin and soft-tissue infections, but it may not always be effective 2.
  • In vitro susceptibilities of doxycycline against MRSA do not always predict in vivo effectiveness 2, 3.
  • Minocycline is preferred over doxycycline for the treatment of CA-MRSA skin and soft-tissue infections due to its higher effectiveness 2, 3.
  • Doxycycline is not a reliable option for treating MRSA infections, and other antibiotics such as linezolid, vancomycin, or daptomycin may be more effective 3, 4, 5.

Comparison with Other Antibiotics

  • Linezolid and minocycline are available for oral administration and are effective in treating MRSA CNS infections 3.
  • Vancomycin is a standard treatment for MRSA infections, but it has limitations such as poor tissue penetration and emerging resistance 4, 5, 6.
  • Daptomycin is a potent anti-MRSA drug that is useful for treating MRSA bacteraemia and endocarditis 3, 4, 5.
  • Other antibiotics such as ceftaroline, telavancin, and tigecycline may also be effective against MRSA infections 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005

Research

Empirical therapy in Methicillin-resistant Staphylococcus Aureus infections: An Up-To-Date approach.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016

Research

Treatment of infections due to resistant Staphylococcus aureus.

Methods in molecular biology (Clifton, N.J.), 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.